In vitro spatial proteomics platform for Parkinson's Disease research
A novel in vitro platform using LUHMES cells and high-throughput imaging to study cerebrospinal fluid-induced proteomic changes in Parkinson's Disease, aiming to identify new molecular targets and enhance drug screening.